The 'G2 Solutions' project, initiated by LIFE Cooperative, was officially awarded a grant by PharmaNL in August under their Shared Development Infrastructure program. This is the second grant we have received from PharmaNL this year, following the February 2024 award for the LIFE Academy under the Human Capital Growth program.
In collaboration with our partners Pivot Park Screening Centre, UMCG, and GenomeScan, this project will focus on developing new technology for improved disease diagnostics and advanced stem cell models to discover new drugs. We aim to make this technology available to academic and commercial partners, thereby collectively enhancing the availability of medicines in the Netherlands.
Peter Ketelaar, Director of LIFE Cooperative: "We are incredibly pleased and grateful for PharmaNL's grant. This recognition underscores the added value and importance of our regional ecosystem in strengthening the Dutch pharmaceutical sector. Through the 'G2 Solutions' project, we are taking a significant step forward in the development of innovative technologies and the acceleration of drug development. The shared use of advanced infrastructure allows us to work faster and more cost-effectively, ultimately contributing to better healthcare for everyone."
PharmaNL is an initiative by and for the Dutch pharmaceutical sector, supported by a national public-private consortium comprising Leiden University Medical Center/Leiden University, Campus Groningen, and Pivot Park Oss.
The PharmaNL Shared Development Infrastructure program focuses on strengthening the Dutch pharmaceutical value chain by expanding shared R&D infrastructure in pharmaceutical hubs. ZonMw executes the PharmaNL program on behalf of the Ministry of Health, Welfare, and Sport (VWS).
The development of this project has been made possible with the support of the Municipality of Groningen and the Municipality of Assen, the Provinces of Groningen, Drenthe, and Fryslân.
Source text: LIFE Cooperative
Source image: PharmaNL
Who is developing the most impactful innovation in Life Sciences & Health in the Northern Netherlands? Five companies are in the running for the LIFE Science Innovation Award 2026: Flux Robotics, Limosa Immunodiagnostics, SPCTR, MimeCure and GlycanScan International. The nominees will present their innovations on Tuesday 22 September during the fifth edition of the LIFE Science Conference in Groningen. An independent jury will select the winner, who will receive a €10,000 cash prize.
ZonMw is expected to open the final call for proposals within the PharmaNL Shared Development Infrastructure (SDI) program line. This program line focuses on strengthening the infrastructure for the development, upscaling, and production of innovative medicines in the Netherlands.
As the largest medical sterilization centre in the Benelux, SteriNoord B.V. provides safe, reliable, and high-quality reprocessing of medical instruments. With state-of-the-art technology and a team of dedicated professionals, the organisation plays an essential role in supporting high-quality healthcare.
